14/08/2024 | Press release | Distributed by Public on 15/08/2024 07:21
Key takeaways:
Cannabidiol (CBD) is an active ingredient of the cannabis plant. Most CBD oil is extracted from hemp and used to make over-the-counter CBD products. Each product works differently in the body. The right one for you depends on what you're using it for.
Research on CBD has shown many possible benefits, such as helping anxiety, insomnia, and pain symptoms. It may also help with substance use disorder and depression. But only one form of CBD, Epidiolex, is FDA approved for certain seizure disorders.
CBD oil isn't a substitute for prescription medications. It can also cause side effects and has drug interactions. So it's best to speak with a healthcare professional before trying CBD oil to make sure it's safe for you.
Cannabidiol (CBD) oil has become increasingly popular over the past few years. Claims that it can help with conditions like anxiety, depression, and insomnia make it appealing to people looking for more natural treatments. Still, as a fairly new treatment option, it's important to learn about the risks and benefits of CBD oil and how to take it.
Cannabidiol, or CBD, is one of about 540 active ingredients found in the cannabis plant. CBD oil can be extracted from all types of cannabis plants. But the CBD oil used in most over-the-counter (OTC) products is extracted from hemp. Hemp is a word used to describe any cannabis plant that contains less than 0.3% THC.
It's not entirely known how CBD works in the body. It's considered a "multi-target" compound, because it interacts with several different types of receptors (binding sites) in the body. It also has antioxidant and anti-inflammatory effects. This is part of the reason it seems to have such a wide variety of uses.
But even though it comes from cannabis, CBD doesn't interact with the body the same way that THC does. That's why CBD doesn't cause the same intoxicating effects as THC. In fact, CBD seems to lessen THC's psychoactive effect if they're combined.
CBD interactions: Learn which medications can interact with over-the-counter (OTC) cannabidiol (CBD) and prescription Epidiolex.
CBD dosages: Here's a review of the FDA-approved dosages for Epidiolex, along with general dosing recommendations for OTC CBD products.
Can CBD get you high? No, but that doesn't mean it isn't psychoactive. Here's how CBD can affect your brain and mood.
For some people, CBD may also cause a placebo effect. This happens when a person expects a medication to work, even if it doesn't actually do anything in the body. Studies on anxiety and pain showed that when people were told they received CBD, their symptoms improved - even if they didn't actually receive it. So approaching CBD with a positive mindset may be as helpful as CBD itself.
Research is ongoing to help understand how CBD works and what conditions it could help treat. Current research on CBD has found that it may help with several different health conditions.
Keep in mind that in most cases, CBD hasn't been clinically proven as an effective treatment for these conditions. Its positive effects are largely based on animal studies or patient-reported effects. More controlled clinical studies are needed to determine the true potential of CBD oil for certain health conditions. And you should always talk to a healthcare professional before trying CBD.
Epidiolex is the only FDA-approved form of CBD. It treats certain types of seizures in adults and children. But Epidiolex isn't the same thing as the CBD oil you can buy OTC. Epidiolex has strict manufacturing guidelines and clinically proven dosing information that can't be applied to other CBD products. So these two products aren't interchangeable.
CBD is also being studied for other epilepsy and other seizure-related conditions - especially those that don't respond well to prescription antiseizure medications.
Good to know: You shouldn't replace your seizure medication or try to treat seizures on your own using CBD oil. It hasn't been proven safe or effective for all types of seizures. And CBD also has side effects and drug interactions to consider. If your medication isn't working well or causing unwanted side effects, talk to your prescriber. They can discuss your options to help you safely manage your seizures.
Early research shows CBD may help improve sleep in people with insomnia. But the results of current clinical studies on CBD and sleep are mixed. It's possible that CBD may be more likely to improve sleep issues related to an underlying health condition, such as anxiety or pain.
Many of the studies showing a positive effect of CBD on sleep were based on patient surveys rather than clinical data. So it's possible that CBD's relaxing effects made people think that they slept better, even if their actual sleep patterns didn't change.
Studies have found that CBD may help people with substance use disorders. CBD may reduce cravings for alcohol, opioids, and stimulants. It may also help lessen opioid withdrawal symptoms.
This is another area where it's best to talk to a healthcare professional before trying CBD. Trying to manage substance use disorders or withdrawal symptoms on your own isn't typically the safest or most effective choice. A medical professional can help you choose the best treatments for your specific needs and help you incorporate CBD safely if they determine it's a good option for you.
CBD seems to have a powerful effect on inflammation. It also may help regulate immune system activity. This may make it a helpful treatment for conditions such as:
Inflammatory bowel disease (although study results are mixed)
These are often complex health conditions, so while CBD may help improve your symptoms, it's not likely to be an effective treatment on its own. So be sure to check with your prescriber to make sure it's safe to take CBD with your other treatments before giving it a try.
CBD may also help with chronic pain. Not only can it help the pain itself, but it may also improve sleep and quality of life for people living with chronic pain. This is likely due to its anti-inflammatory effects.
A small study showed improvement in nerve pain symptoms with topical CBD. Early studies also show that oral CBD may help prevent nerve pain caused by certain types of chemotherapy treatment. More in-depth research on CBD and nerve pain is ongoing.
Evidence on CBD for pain is mixed, and most studies look at CBD combined with THC, not CBD alone. So more research is needed to know more about CBD's effect on pain.
Anxiety is one of the most common reasons people turn to CBD oil. In a survey of young adults, over 65% of participants reported using CBD for stress relief.
There's some evidence that CBD can help reduce anxiety related to pain as well as social anxiety. A small study also showed that at certain doses, CBD may help with performance-related anxiety. And a more recent study found that CBD-dominant cannabis reduced anxiety better than THC-dominant or equal THC and CBD products.
There's some evidence CBD doses under 300 mg may be less effective for anxiety. But responses may vary between people, and an optimal dosing regimen hasn't been clearly established.
Preliminary studies on CBD suggest that it could be helpful for depression. Like antidepressant medications, it appears to alter serotonin levels in the brain.
Several small trials show that CBD may help lessen symptoms of psychosis with fewer side effects than most other antipsychotic medications. But more long-term safety data is needed.
CBD is also currently being studied for other conditions, such as:
Post-traumatic stress disorder
Alzheimer's disease
Parkinson's disease
Huntington's disease
Type 2 diabetes
Certain cancers
Graft-versus-host disease
Skin conditions such as acne, psoriasis, and dermatitis
As of yet, there's no clear evidence - one way or the other - if CBD is effective for these conditions.
CBD is generally well tolerated, but it does have some side effects and risks to be aware of. The most common are:
Drowsiness
Diarrhea
Decreased appetite
Fatigue
These side effects are more likely at higher doses and often go away with time as your body adjusts to CBD. But if they don't, consider lowering the amount of CBD you're taking. You can also talk to your healthcare team for guidance.
The package insert for Epidiolex states that CBD may also increase the risk of suicidal thoughts or behaviors, although this isn't clearly understood. If you notice a negative change in your mood after you start taking CBD, contact a healthcare professional right away.
Sometimes, but not always. Epidiolex is the only form of CBD that's FDA approved and proven safe and effective when used as directed.
CBD is considered a dietary supplement by the FDA. This means even though you can buy it OTC, the safety and purity isn't regulated. Unreliable labeling or contaminants in a CBD product could make it unsafe for you. You can learn more about choosing a quality CBD product here.
Epidiolex is the only form of CBD that's considered safe for seizure disorders in children. But that doesn't mean all CBD products are safe to give to children. As mentioned, CBD products sold OTC aren't well regulated and may contain pesticides and heavy metals that are harmful to children. There also isn't enough research to know how CBD can affect a developing brain.
If you're interested in CBD as a treatment option for your child, it's best to speak to a healthcare professional for guidance.
There are a few things to consider when taking CBD oil: the product category, the dosage form, and the dose.
All CBD oil falls into one of three main categories:
Full-spectrum CBD: A full-spectrum oil contains CBD along with all of the other active ingredients found in the cannabis plant. This includes terpenes, flavonoids, and other cannabinoids, including THC. But only full-spectrum CBD products with less than 0.3% THC can be sold OTC.
Broad-spectrum CBD: These products are similar to full-spectrum CBD, but they don't contain any THC. They may contain other cannabinoids though, such as CBG or CBN.
CBD isolate: These products only contain CBD - no other active ingredients from the cannabis plant are included. Often, CBD isolate is lab-made; it's not extracted from cannabis or hemp plants at all.
Full- and broad-spectrum CBD products contain more active ingredients than CBD isolate. But CBD isolate may be a safer option if you're concerned about testing positive for cannabis on a drug test.
CBD oil is used to make most CBD products. These can range from capsules, gummies, and brownies to lotions, vape cartridges, and sublingual drops. Each of these products works differently in your body. The most common forms of CBD include:
Inhaled (vaping or smoking)
Sublingual (under the tongue)
Oral (capsules or food-based edibles)
Topical (cream or lotion)
Transdermal (patches or gels/creams that are formulated to pass through the skin into the bloodstream)
Inhaling CBD works the quickest, but the effects don't last very long. So people often choose to inhale CBD when they need fast relief, such as for anxiety or muscle spasms. But inhaling CBD can be harmful to your lungs, so it isn't an ideal choice.
Sublingual and oral forms of CBD take longer to work (1 to 2 hours or more), but they also last longer once they take effect. So they may be better for ongoing symptoms that need long-lasting treatment, such as chronic pain.
Some oral and sublingual forms of CBD use a new technology called nano-formulation. This allows your body to absorb them faster so they don't take as long to work. But they also won't last as long. These products may be a good alternative to inhaled CBD, since they work pretty fast and don't last a long time.
Most topical CBD products only work on the surface of the skin, so they're best for skin-related conditions. But there are some patches, gels, and creams that are formulated to pass through the skin into the bloodstream (transdermal products). These may be helpful for muscle or joint pain when applied to the affected area, but there's not a lot of evidence behind their use.
There are no universal dosing guidelines on how much CBD oil you should take (except in the case of Epidiolex). Studies on CBD have looked at daily doses ranging from 16 mg to 1,000 mg. In general, experts recommend starting with a low dose of CBD and slowly increasing it over time.
For pain, a general guideline is to start with 5 mg of CBD twice a day. You can then increase your dose by 10 mg every 2 to 3 days up to 40 mg a day. Research suggests that higher doses of CBD (300 mg to 600 mg) may be better for anxiety. But remember to speak with a healthcare professional first. They can help you choose the right dose for your needs.
Cannabidiol (CBD) is an active ingredient found in the cannabis plant. Most over-the-counter CBD products are extracted from hemp. Only one form of CBD oil, Epidiolex, is FDA approved for certain types of epilepsy in adults and children.
There's some evidence CBD may help with anxiety, pain, and sleep. It may also help with depression and substance use disorders. But there aren't many controlled clinical trials on CBD oil. So we don't know for sure if it's safe or effective for these conditions or what dosage may work best.
CBD products sold OTC aren't well-regulated, so use caution when purchasing them. And CBD oil isn't a substitute for prescription medications. It's best to talk to a healthcare professional before starting CBD. They can help you find the right dose for your needs and screen for any possible drug interactions.
If you or someone you know struggles with substance use, help is available. Call SAMHSA's National Helpline at 1-800-662-HELP (4357) to learn about resources in your area.
Atalay, S., et al. (2020). Antioxidative and anti-inflammatory properties of cannabidiol. Antioxidants.
Bhaskar, A., et al. (2021). Consensus recommendations on dosing and administration of medical cannabis to treat chronic pain: Results of a modified Delphi process. Journal of Cannabis Research.
Bidwell, L. C., et al. (2024). Acute and extended anxiolytic effects of cannabidiol in cannabis flower: A quasi-experimental ad libitum use study. Cannabis and Cannabinoid Research.
Campbell, C. T., et al. (2017). Cannabinoids in pediatrics. The Journal of Pediatric Pharmacology and Therapeutics.
Casiraghi, A., et al. (2020). Topical administration of cannabidiol: Influence of vehicle-related aspects on skin permeation process. Pharmaceuticals.
Cather, J. C., et al. (2020). Cannabidiol primer for healthcare professionals. Proceedings.
Davies, C., et al. (2019). Cannabidiol as a potential treatment for psychosis. Therapeutic Advances in Psychopharmacology.
De Vita, M. J., et al. (2022). The effects of cannabidiol and analgesic expectancies on experimental pain reactivity in healthy adults: A balanced placebo design trial. Experimental and Clinical Psychopharmacology.
Devinsky, O., et al. (2014). Cannabidiol: Pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders. Epilepsia.
Ebadi, S. R., et al. (2023). The effect of cannabidiol on seizure features and quality of life in drug-resistant frontal lobe epilepsy patients: A triple-blind controlled trial. Frontiers in Neurology.
Frane, S., et al. (2022). Cannabidiol as a treatment for arthritis and joint pain: An exploratory cross-sectional study. Journal of Cannabis Research.
Gardener, H., et al. (2022). Heavy metal and phthalate contamination and labeling integrity in a large sample of US commercially available cannabidiol (CBD) products. Science of The Total Environment.
Golub, V., et al. (2021). Cannabidiol therapy for refractory epilepsy and seizure disorders. Advances in Experimental Medicine and Biology.
Grifoni, L., et al. (2022). Promising nanocarriers to enhance solubility and bioavailability of cannabidiol for a plethora of therapeutic opportunities. Molecules.
Hasenoehrl, C., et al. (2017). Cannabinoids for treating inflammatory bowel diseases: Where are we and where do we go?Expert Review of Gastroenterology & Hepatology.
Huestis, M. A., et al. (2019). Cannabidiol adverse effects and toxicity. Current Neuropharmacology.
Jazz Pharmaceuticals, Inc. (2023). Epidiolex (cannabidiol) oral solution [package insert].
Johnson, R. (2019). Defining hemp: a fact sheet. Congressional Research Service.
Kudrich, C., et al. Adjunctive management of opioid withdrawal with the nonopioid medication cannabidiol. Cannabis and Cannabinoid Research.
Larsen, C., et al. (2020). Dosage, efficacy and safety of cannabidiol administration in adults: A systematic review of human trials. Journal of Clinical Medicine Research.
Linares, I. M., et al. (2019). Cannabidiol presents an inverted U-shaped dose-response curve in a simulated public speaking test. Brazilian Journal of Psychiatry.
Lowin, T., et al. (2020). Cannabidiol (CBD): A killer for inflammatory rheumatoid arthritis synovial fibroblasts. Cell Death & Disease.
Makhakhe, L. (2022). Topical cannabidiol (CBD) in skin pathology - A comprehensive review and prospects for new therapeutic opportunities. South African Family Practice.
Meissner, H., et al. (2024). Cannabidiol (CBD). StatPearls.
Millar, S. A., et al. (2018). A systematic review on the pharmacokinetics of cannabidiol in humans. Frontiers in Pharmacology.
Naftali, T., et al. (2017). Low-dose cannabidiol is safe but not effective in the treatment for crohn's disease, a randomized controlled trial. Digestive Diseases and Sciences.
Narayan, A. J., et al. (2022). Cannabinoid treatments for anxiety: A systematic review and consideration of the impact of sleep disturbance. Neuroscience & Biobehavioral Reviews.
National Center for Biotechnology Information. (2024). PubChem compound summary for CID 644019, cannabidiol. PubChem.
National Center for Complementary and Integrative Health. (2019). Cannabis (marijuana) and cannabinoids: What you need to know.
Navarrete, F., et al. (2021). Role of cannabidiol in the therapeutic intervention for substance use disorders. Frontiers in Pharmacology.
Nichols, J. M., et al (2020). Immune responses regulated by cannabidiol. Cannabis and Cannabinoid Research.
Nielsen, S. W., et al. (2022). Oral cannabidiol for prevention of acute and transient chemotherapy-induced peripheral neuropathy. Support Care in Cancer: Official Journal of the Multinational Association of Supportive Care in Cancer.
Prud'homme, M., et al. (2015). Cannabidiol as an intervention for addictive behaviors: A systematic review of the evidence. Substance Abuse: Research and Treatment.
Ranum, R. M., et al. (2023). Use of cannabidiol in the management of insomnia: A systematic review. Cannabis and Cannabinoid Research.
Rudroff, T., et al. (2021). Cannabidiol to improve mobility in people with multiple sclerosis. Frontiers in Neurology.
Sholler, D. J., et al. (2020). Therapeutic efficacy of cannabidiol (CBD): A review of the evidence from clinical trials and human laboratory studies. Current Addiction Reports.
Skelley, J. W., et al. (2020). Use of cannabidiol in anxiety and anxiety-related disorders. Journal of the American Pharmacists Association.
Spinella, T. C., et al. (2021). Evaluating cannabidiol (CBD) expectancy effects on acute stress and anxiety in healthy adults: A randomized crossover study. Psychopharmacology.
Villanueva, M. R. B., et al. (2022). Efficacy, safety, and regulation of cannabidiol on chronic pain: A systematic review. Cureus.
Wheeler, M., et al. (2020). CBD (cannabidiol) product attitudes, knowledge, and use among young adults. Substance Use & Misuse.
Xu, D. H., et al. (2020). The effectiveness of topical cannabidiol oil in symptomatic relief of peripheral neuropathy of the lower extremities. Current Pharmaceutical Biotechnology.
By signing up, I agree to GoodRx's Terms and Privacy Policy, and to receive marketing messages from GoodRx.